Accepted at 11:56 a.m. Sep, 14, 2023 by Ahmed7
Author: ms1100
Co-authors: Ahmed7
Related Note: 1461599525155
Rationale for change

AMBOSS:

Nonspecific muscarinic antagonist.

Central antiemetic effect at the area postrema and on the vestibular system
Peripheral antiemetic effect via inhibition of the vagus nerve

Anticholinergic side effects: dry mouth, mydriasis, tachycardia, urinary retention
Antidote: physostigmine (cholinesterase inhibitor)


**Open to other edit suggestions, but the card implies it is a specific M1 antagonist.

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy 2
Empty field
Sketchy Extra
Picmonic
Empty field
Pixorize

Physeo
Empty field
OME

Additional Resources
One by one
Empty field
#AK_Step1_v12::#FirstAid::09_Gastrointestinal::05_Pharm::15_Motion_Sickness_Drugs #AK_Step1_v12::#FirstAid::12_Neuro_&_Special_Senses::02_Anatomy_&_Physiology::14_Vomiting_Center #AK_Step1_v12::#SketchyPharm::01_Autonomic_Drugs::01_Parasympathetic::03_Muscarinic_antagonists #AK_Step1_v12::#Bootcamp::Pharmacology::03_Autonomic_System::09_Muscarinic_Antagonists !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step1_v12::#Pixorize::03_Pharmacology::03_Anticholinergics::05_Scopolamine #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::01_GI::01_Antiemetic_Agents #AK_Step1_v12::^Other::^HighYield::2-RelativelyHighYield #AK_Step1_v12::#UWorld::175 #AK_Step1_v12::#Bootcamp::Gastroenterology::10_Pharmacology::06_Antiemetics #AK_Step1_v12::#FirstAid::05_Pharmacology::03_Toxicities_&_Side_Effects::10_Drug_reactions_-_multiorgan #AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#SketchyPharm::05_GI_&_Endocrine::06_Retired_Lessons::01_Antiemetic_Agents_[Old_Version] #AK_Step1_v12::^Systems::GI::pharm #AK_Step1_v12::#OME_banner #AK_Step1_v12::#B&B::15_Neuro::04_ANS::03_ANS_Drugs-_Acetylcholine